Assura Plc
Assura Plc (ARSSF) Stock Overview
Explore Assura Plc’s financial performance, market position, analyst ratings, and future outlook.
ARSSF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Assura Plc (ARSSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.64.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.47 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Mr. Jonathan Stewart Murphy ACA, MBA
84
The Brew House, Warrington
2021